Please select a community
Automation & Microfluidics
Biologics & Bioprocessing
Chemical Process Scale Up
Food & Beverage Analysis
Forensic Science & Clinical Toxicology
Genotyping & Gene Expression
LIMS & ELNs
Metabolomics & Lipidomics
Molecular & Clinical Diagnostics
Next Gen Sequencing
Stem Cells, Cellular Therapy & Biobanking
Become a Member
Add My Products
DeNovix Showcases Spectrophotometer / Fluorometer System at AACR
Monday, April 18, 2016
Company will present its DS-11 FX+ Spectrophotometer / Fluorometer at this year’s AACR 2016 meeting in New Orleans, LA.
Horizon Introduces New High Throughput Platform
Friday, April 15, 2016
Company has announced that it has launch of a new platform for immuno-oncology research.
New Lung Cancer Test is Now Available in Europe
Thursday, April 07, 2016
Company has announced the commercial availability of new In Vitro Diagnostic test for non-squamous non-small cell lung cancer.
Horizon Discovery Group plc Launches HDx™ RNA Fusion Reference Standards
Wednesday, March 23, 2016
Company has launched HDx™ RNA fusion reference standards optimization and validation of targeted RNA-seq, endpoint RT-PCR or RT-qPCR assays.
Tews Laboratory Uses LaVision BioTec UltraMicroscope
Tuesday, March 22, 2016
Company has announced that the Tews Laboratory uses an UltraMicroscope for research into the molecular mechanisms of tumor invasion and enhanced imaging of cells.
Primary Human Cancer Cells
Wednesday, March 16, 2016
Company has announced that the range of primary human cancer cells obtained directly from a variety tumor types, including breast, colon and prostate.
DNASTAR Releases Lasergene 13 Software to Enhance RNA Research
Thursday, March 03, 2016
Company has announced the release of Lasergene 13 Software to enhance RNA research on model and non-model organisms on standard desktop computers.
PerkinElmer’s LabChip® NGS 3K Assay Conserves Rare Sample Types and Provides Enhanced Research Workflows
Wednesday, March 02, 2016
Company has announced the launch of its new LabChip® NGS 3K assay for advanced genomics and cancer research, drug development, and next generation sequencing.
New Chambers Designed to Provide Optimum Uniformity for Stable Environmental Conditions
Monday, February 15, 2016
Company has designed the Environmental Chambers which use a unique airflow system for advanced temperature control for drug stability testing, shelf-life testing, insect studies or controlled storage.
Showing Results 1 - 10 of 744
Detection of HPV in First-Void Urine
Similar sensitivity of HPV test on first void urine sample compared to cervical smear.
Potential “Good Fat” Biomarker
New method to measure the activity of energy consuming brown fat cells could ease the testing weight loss drugs.
Shape Of Tumor May Affect Whether Cells Can Metastasize
Illinois researchers found that the shape of a tumor may play a role in how cancer cells become primed to spread.
MicroRNA Pathway Could Lead to New Avenues for Leukemia Treatment
Cancer researchers at the University of Cincinnati have found a particular signaling route in microRNA (miR-22) that could lead to targets for acute myeloid leukemia, the most common type of fast-growing cancer of the blood and bone marrow.
Analysis of Dog Genome will Provide Insight into Human Disease
An important model in studying human disease, the non-coding RNA of the canine genome is an essential starting point for evolutionary and biomedical studies – according to a new study led by The Genome Analysis Centre (TGAC).
New Blood Test for The Earlier Diagnosis of Breast Cancer Spread
Researchers at University of Westminster have confirmed that a new blood test can detect if breast cancer has spread to other parts of the body.
First Gene Therapy Successful Against Human Aging
American woman gets biologically younger after gene therapies.
Targeting an ‘Undruggable’ Cancer Gene
RAS genes are mutated in more than 30 percent of human cancers and represent one of the most sought-after cancer targets for drug developers.
Altered Metabolism of Four Compounds Drives Glioblastoma Growth
Findings suggest new ways to treat the malignancy, slow its progression and reveal its extent more precisely.
Improving Engineered T-Cell Cancer Treatment
Purdue University researchers may have figured out a way to call off a cancer cell assassin that sometimes goes rogue and assign it a larger tumor-specific "hit list."
Advertise On This Site
Terms & Conditions
©2016 Technology Networks
, all rights reserved.
Latest presentations and webinars
3,000+ scientific and medical posters
4,400+ scientific videos
JOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!